Cargando…

Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study

Women with hormone-dependent breast cancer are treated with aromatase inhibitors (AI) to slow disease progression by decreasing estrogen levels. However, AI have adverse effects, including pain, with potentially serious impact on quality of life (QOL) and treatment compliance. We evaluated quality o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laroche, Françoise, Perrot, Serge, Medkour, Terkia, Cottu, Paul-Henri, Pierga, Jean-Yves, Lotz, Jean-Pierre, Beerblock, Karine, Tournigand, Christophe, Chauvenet, Laure, Bouhassira, Didier, Coste, Joël
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678681/ https://www.ncbi.nlm.nih.gov/pubmed/29117210 http://dx.doi.org/10.1371/journal.pone.0187165

Ejemplares similares

Osteopathic medicine for fibromyalgia: a sham-controlled randomized clinical trial
por: Coste, Joël, et al.
Publicado: (2021)

Response to Alvarez et al.
por: Coste, Joël, et al.
Publicado: (2021)

“Let’s Talk about OA Pain”: A Qualitative Analysis of the Perceptions of People Suffering from OA. Towards the Development of a Specific Pain OA-Related Questionnaire, the Osteoarthritis Symptom Inventory Scale (OASIS)
por: Cedraschi, Christine, et al.
Publicado: (2013)

Napping Reverses Increased Pain Sensitivity Due to Sleep Restriction
por: Faraut, Brice, et al.
Publicado: (2015)

Three dimensions of pain in osteoarthritis: development and validation of the Osteoarthritis Symptom Inventory Scale
por: Perrot, Serge, et al.
Publicado: (2023)

Are joint and soft tissue injections painful? Results of a national French cross-sectional study of procedural pain in rheumatological practice
por: Perrot, Serge, et al.
Publicado: (2010)

Fibromyalgia in the workplace: risk factors for sick leave are related to professional context rather than fibromyalgia characteristics— a French national survey of 955 patients
por: Laroche, F., et al.
Publicado: (2019)

Placental Aromatase Is Deficient in Placental Ischemia and Preeclampsia
por: Perez-Sepulveda, Alejandra, et al.
Publicado: (2015)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

Regorafenib as a single-agent in the treatment of patients with gastrointestinal tumors: an overview for pharmacists
por: Rey, Jean-Baptiste, et al.
Publicado: (2014)

Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy
por: Cabel, Luc, et al.
Publicado: (2020)

Dimensionality and invariance of ADL, IADL, BI-M2/WG-SS, and GALI in large surveys in France (2008–2014) and implications for measuring disability in epidemiology
por: Coste, Joël, et al.
Publicado: (2023)

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study
por: Bidard, François-Clément, et al.
Publicado: (2012)

Long-term safety of aromatase inhibitors in the treatment of breast cancer
por: Nabholtz, Jean-Marc A
Publicado: (2008)

Effect of local aromatase inhibition in endometriosis using a new chick embryo chorioallantoic membrane model
por: Pluchino, Nicola, et al.
Publicado: (2019)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy, Anne-Sophie, et al.
Publicado: (2018)

Sequencing of aromatase inhibitors
por: Bertelli, G
Publicado: (2005)

Modulation of Aromatase by Phytoestrogens
por: Lephart, Edwin D.
Publicado: (2015)

Aromatase in the Human Brain
por: Azcoitia, Iñigo, et al.
Publicado: (2021)

Aromatase expression and role of estrogens in male gonad : a review
por: Carreau, Serge, et al.
Publicado: (2003)

Aromatase and Dual Aromatase-Steroid Sulfatase Inhibitors from the Letrozole and Vorozole Templates
por: Wood, Paul M, et al.
Publicado: (2011)

Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity
por: Hong, Yanyan, et al.
Publicado: (2009)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy-Petit, Anne-Sophie, et al.
Publicado: (2016)

Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen
por: Basu, Samar, et al.
Publicado: (2015)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
por: Lerebours, Florence, et al.
Publicado: (2021)

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer
por: Tanguy, Marie-Laure, et al.
Publicado: (2018)

PELICAN-IPC 2015-016/Oncodistinct-003: A Prospective, Multicenter, Open-Label, Randomized, Non-Comparative, Phase II Study of Pembrolizumab in Combination With Neo Adjuvant EC-Paclitaxel Regimen in HER2-Negative Inflammatory Breast Cancer
por: Bertucci, Alexandre, et al.
Publicado: (2020)

Is herpes zoster an additional complication in old age alongside comorbidity and multiple medications? Results of the post hoc analysis of the 12-month longitudinal prospective observational ARIZONA cohort study
por: Pickering, Gisèle, et al.
Publicado: (2016)

Circulating tumor cells in breast cancer
por: Bidard, Francois-Clement, et al.
Publicado: (2016)

Bone loss and the aromatase inhibitors
por: Lester, J, et al.
Publicado: (2005)

Aromatase inhibitors in male sex
por: Singh, Santosh Kumar
Publicado: (2013)

Aromatase inhibitors in the treatment of endometriosis
por: Słopień, Radosław, et al.
Publicado: (2016)

Molecular Docking of Aromatase Inhibitors
por: Suvannang, Naravut, et al.
Publicado: (2011)

Aromatase Inhibitors in Erectile Dysfunction
por: Singh, Santosh
Publicado: (2021)

Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment
por: Bollet, Marc A, et al.
Publicado: (2009)

Helping Patients Communicate With Oncologists When Cancer Treatment Resistance Occurs to Develop, Test, and Implement a Patient Communication Aid: Sequential Collaborative Mixed Methods Study
por: Brédart, Anne, et al.
Publicado: (2022)

Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort
por: Blondon, Marc, et al.
Publicado: (2022)

Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial
por: Cabel, Luc, et al.
Publicado: (2021)

Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness
por: de Andrade, Daniel Ciampi, et al.
Publicado: (2010)

Role of aromatase inhibitors in breast cancer
por: Carpenter, R, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_6p5ts3pol0sn2kmv3hnrm8etes